Dimensional Fund Advisors LP Supernus Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

$391 Billion
Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,903,727 shares of SUPN stock, worth $93.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,903,727

Previous 2,878,545 0.87%

Holding current value

$93.9 Million

Previous $104 Million 8.64%

% of portfolio

0.02%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$31.17 - $40.0 $784,922 - $1.01 Million	25,182 Added 0.87%	2,903,727 $95.1 Million
Q4 2024 Feb 13, 2025	SELL	$31.89 - $37.83 $126,284 - $149,806	-3,960 Reduced 0.14%	2,878,545 $104 Million
Q3 2024 Nov 07, 2024	BUY	$25.77 - $35.16 $402,475 - $549,128	15,618 Added 0.54%	2,882,505 $89.9 Million
Q2 2024 Aug 09, 2024	BUY	$25.99 - $33.85 $8.06 Million - $10.5 Million	309,966 Added 12.12%	2,866,887 $76.7 Million
Q1 2024 May 10, 2024	BUY	$27.11 - $35.17 $2.73 Million - $3.54 Million	100,552 Added 4.09%	2,556,921 $87.2 Million
Q4 2023 Feb 07, 2024	BUY	$22.72 - $29.68 $3.22 Million - $4.2 Million	141,586 Added 6.12%	2,456,369 $71.1 Million
Q3 2023 Nov 09, 2023	SELL	$27.57 - $32.91 $3.2 Million - $3.82 Million	-116,133 Reduced 4.78%	2,314,783 $63.8 Million
Q2 2023 Aug 09, 2023	BUY	$29.91 - $38.73 $1.19 Million - $1.54 Million	39,650 Added 1.66%	2,430,916 $73.1 Million
Q1 2023 May 12, 2023	BUY	$34.93 - $42.03 $276,680 - $332,919	7,921 Added 0.33%	2,391,266 $86.6 Million
Q4 2022 Feb 09, 2023	BUY	$31.09 - $37.88 $3.51 Million - $4.28 Million	112,865 Added 4.97%	2,383,345 $85 Million
Q3 2022 Nov 10, 2022	BUY	$28.79 - $35.41 $902,710 - $1.11 Million	31,355 Added 1.4%	2,270,480 $76.9 Million
Q2 2022 Aug 12, 2022	BUY	$25.33 - $34.25 $451,000 - $609,821	17,805 Added 0.8%	2,239,125 $64.8 Million
Q1 2022 May 13, 2022	SELL	$28.51 - $32.9 $550,271 - $635,002	-19,301 Reduced 0.86%	2,221,320 $71.8 Million
Q4 2021 Feb 09, 2022	SELL	$26.37 - $34.22 $907,919 - $1.18 Million	-34,430 Reduced 1.51%	2,240,621 $65.3 Million
Q3 2021 Nov 12, 2021	SELL	$23.54 - $31.39 $26,694 - $35,596	-1,134 Reduced 0.05%	2,275,051 $60.7 Million
Q2 2021 Aug 12, 2021	BUY	$26.72 - $33.19 $3.85 Million - $4.78 Million	144,093 Added 6.76%	2,276,185 $70.1 Million
Q1 2021 May 14, 2021	BUY	$24.15 - $31.45 $4.76 Million - $6.2 Million	197,229 Added 10.19%	2,132,092 $55.8 Million
Q4 2020 Feb 25, 2021	BUY	$17.7 - $25.81 $34.2 Million - $49.9 Million	1,934,863 New	1,934,863 $48.7 Million

Others Institutions Holding SUPN

# of Institutions

305

Shares Held

60.8M

Call Options Held

8.8K

Put Options Held

6.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.73B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Supernus Pharmaceuticals, Inc. Transaction History